Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer
Tuesday, December 9, 2008 - 18:21
in Health & Medicine
Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute.
Read the whole article on Physorg
More from Physorg
Related
- Nonhormonal treatment regimens improve survival in patients with metastatic breast cancerTue, 9 Dec 2008, 18:22:21 EST
- Adding taxotere to chemotherapy regimen improves survival in early breast cancerMon, 15 Sep 2008, 20:29:21 EDT
- HER2 levels may aid in treatment selection for metastatic breast cancerTue, 2 Dec 2008, 10:49:47 EST
- Low-dose estrogen shown safe and effective for metastatic breast cancerTue, 18 Aug 2009, 16:32:01 EDT
- Less-toxic drug prolongs survival in metastatic breast cancerTue, 26 May 2009, 16:37:51 EDT